欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号DE/H/5361/001
药品名称Sorafenib-AbZ 200 mg Filmtabletten
活性成分
    • SORAFENIB TOSILATE 274.0 mg
剂型Film-coated tablet
上市许可持有人ratiopharm GmbH Graf-Arco-Str. 3 89079 Ulm Germany
参考成员国 - 产品名称Germany (DE)
Sorafenib-AbZ 200 mg Filmtabletten
互认成员国 - 产品名称
    • Denmark (DK)
      Sorafenib "Teva"
    • Belgium (BE)
      Sorafenib Teva 200 mg filmomhulde tabletten
    • Netherlands (NL)
      Sorafenib Teva 200 mg, filmomhulde tabletten
    • United Kingdom (Northern Ireland) (XI)
    • France (FR)
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Greece (GR)
    • Sweden (SE)
    • Poland (PL)
      Sorafenib Teva
    • Latvia (LV)
      Sorafenib Teva 200 mg apvalkotās tabletes
    • Lithuania (LT)
      Sorafenib Teva 200 mg plėvele dengtos tabletės
    • Estonia (EE)
      SORAFENIB TEVA
    • Hungary (HU)
      SORAFENIB TEVA 200 mg filmtabletta
    • Bulgaria (BG)
    • Czechia (CZ)
      Sorafenib Teva
    • Slovakia (SK)
      Sorafenib Teva 200 mg
    • Slovenia (SI)
      Sorafenib Teva 200 mg filmsko obložene tablete
    • Croatia (HR)
      Sorafenib Teva 200 mg filmom obložene tablete
许可日期2018/12/19
最近更新日期2023/12/22
药物ATC编码
    • L01XE05 sorafenib
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase